Evaluation of the Analgesic Effects of Prolonged-release Oxycodone and of Levodopa, Versus Placebo, on Central Neuropathic Pain in Parkinson's Disease: OXYDOPA Trial
Phase of Trial: Phase II/III
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Oxycodone (Primary) ; Levodopa
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms OXYDOPA
- 07 Mar 2018 Planned End Date changed from 1 Jan 2018 to 1 Sep 2018.
- 07 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2018.
- 11 Jul 2017 Status changed from not yet recruiting to recruiting.